AlphaMark Advisors’s Insulet PODD Stock Holding History

AlphaMark Advisors’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-82	Closed	-$19K	–	699
2022 Q3	$19K	Buy	+82	New	+$20.5K	0.01%	336

Other funds holding PODD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AlphaMark Advisors's PODD Position: Q4 2022 in Review

AlphaMark Advisors sold out of Insulet (PODD) in Q4 2022, closing a stake of 82 shares — an estimated $19K sold.

AlphaMark Advisors first reported a position in PODD in Q3 2022 and held it in 1 quarter. The position peaked at $19K in Q3 2022. 525 funds tracked by Wall St. Rank hold PODD as of Q4 2022.

AlphaMark Advisors reported no remaining Insulet position as of Q4 2022 after selling out during the quarter.
AlphaMark Advisors sold 82 Insulet shares in Q4 2022, an estimated $19K.
AlphaMark Advisors first reported a position in Insulet in Q3 2022 and held it in 1 quarter.
AlphaMark Advisors's Insulet position peaked at $19K in Q3 2022.
525 funds tracked by Wall St. Rank held Insulet as of Q4 2022.

Based on AlphaMark Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.